Dyax Closes $230 Million Public Offering of Common Stock Apr 13, 2015 02:12PM
Dyax Corp. to Participate in the 14th Annual Needham Healthcare Conference Apr 9, 2015 08:00AM
Dyax Corp (DYAX) Prices Upsized 7.4M Share Common Offering at $27/Share Apr 8, 2015 06:11AM
Dyax Announces Pricing of $200 Million Public Offering of Common Stock Apr 7, 2015 08:47PM
Dyax Corp (DYAX) to Offer 7M Common Shares Apr 6, 2015 04:02PM


Apr 6, 2015 04:01PM Dyax Announces Proposed Public Offering of 7,000,000 Shares of Common Stock
Apr 1, 2015 06:18AM Dyax Corp. (DYAX) PT Raised to $30 at Needham & Company
Mar 25, 2014 10:34AM Notable Analyst Rating Changes 03/25: (SOL) (RAX) (PCAR) Upgraded; (HIMX) (PHM) (ACI) Downgraded
Mar 14, 2014 09:06AM Dyax (DYAX) Prices 8M Common Offering at $9.25/Share
Feb 19, 2014 10:09AM Eli Lilly (LLY) Ramucirumab Data a Positive for Dyax (DYAX), Needham & Company Says
Feb 18, 2014 07:47AM Dyax Corp. (DYAX) Target Lifted to $13 at Needham & Company on DX2930 Potential
Oct 8, 2013 04:07PM Dyax (DYAX) Announces Common Stock Offering
Oct 25, 2012 10:53AM Dyax (DYAX) a Buy on Franchise and Pipeline Optimism
Jul 20, 2012 08:24AM Needham & Company Maintains a 'Buy' on Dyax Corp. (DYAX); Strong Kalbitor Growth Trends
Jun 20, 2012 07:33AM Needham & Company Starts Dyax Corp. (DYAX) at Buy; Returning to Investor Radar as Kalbitor Grows
Jul 28, 2011 07:23AM Needham & Company Maintains a 'Buy' on Dyax Corp. (DYAX); Summer Brings Rising Temperatures Along with Rising Revenues
May 31, 2011 02:34PM Needham & Company Reiterates a 'Buy' on Dyax Corp. (DYAX); Expand Current KALBITOR Commercialization Agreement to Include Latin America and Southeast Asia
Feb 24, 2011 08:08AM Needham & Company Reiterates a 'Buy' on Dyax (DYAX); L-T Sales Challenges, But Growth Potential
Jan 5, 2011 08:09AM Needham & Company Reiterates a 'Buy' on Dyax Corp. (DYAX); The Company Continues to Focus on Building the Patient Base in HAE Orphan Indication For Long-Term Revenue Generation;
Sep 21, 2010 08:00AM Needham & Company Reiterates a 'Buy' on Dyax (DYAX); Company Remains Focused on Building Steadily Growing Patient Base
Apr 7, 2010 08:02AM Needham & Company Reiterates a 'Buy' Rating on Dyax (DYAX); Three Building Blocks For Growth
Mar 25, 2010 09:00AM Dyax (DYAX) Prices 17M Common Offering at $3.25/Share
Mar 24, 2010 04:04PM Dyax Corp. (DYAX) Announces Common Offering
Dec 2, 2009 09:56AM Needham Lifts Price Target on Dyax (DYAX) to $8
Jul 22, 2009 02:28PM Needham & Co Upgrades Dyax (DYAX) to Buy
Feb 5, 2009 09:51AM Needham & Co Downgrades Dyax Corp. (DYAX) to Hold